Akalu Temesgen Yihunie, Clements Archie C A, Liyew Alemneh Mekuriaw, Gilmour Beth, Murray Megan B, Alene Kefyalew Addis
School of Population Health, Faculty of Health Sciences, Curtin University, Perth, Western Australia, Australia.
Geospital and Tuberculosis Research Team, Telethon Kids Institute, Perth, Western Australia, Australia.
EClinicalMedicine. 2024 Oct 21;77:102898. doi: 10.1016/j.eclinm.2024.102898. eCollection 2024 Nov.
Post-tuberculosis (TB) sequelae present a significant challenge in the management of TB survivors, often leading to persistent health issues even after successful treatment. Identifying risk factors associated with post-TB sequelae is important for improving outcomes and quality of life of TB survivors. This systematic review and meta-analysis aims to identify risk factors associated with long-term physical sequelae among TB survivors.
We systematically searched Medline, Embase, PROQUEST, and Scopus for studies on long-term physical sequelae among TB survivors up to December 12, 2023. The primary outcome of interest was to quantify risk factors of long-term physical sequelae (i.e., respiratory, hepatic, hearing, neurological, visual, renal, and musculoskeletal sequelae). We included all forms of TB patients who experienced long-term physical sequelae. We used narrative synthesis for risk factors reported once and random-effect meta-analysis for primary outcomes with two or more studies. Findings were presented with odds ratios (OR) and 95% confidence intervals (CI). Publication bias was assessed using funnel plots and Egger regression, and heterogeneity was examined with a Galbraith radial plot. The protocol was registered on Prospero (CRD42021250909).
A total of 73 articles from 28 countries representing 31,553 TB-treated patients were included in the narrative synthesis, with 64 of these studies included in the meta-analysis. Risk factors associated with post-TB lung sequelae include older age (OR = 1.62, 95% CI: 1.07-2.47), previous TB treatment history (OR = 3.43, 95% CI: 2.37-4.97), smoking (OR = 1.41, 95% CI: 1.09-1.83), alcohol consumption (OR = 1.84, 95% CI: 1.04-3.25), smear-positive pulmonary TB diagnosis (OR = 3.11, 95% CI: 1.77-6.44), and the presence of radiographic evidence of pulmonary lesions at the commencement of treatment (OR = 2.04, 95% CI: 1.07-3.87). Risk factors associated with post-TB liver injury included pre-existing hepatitis (OR = 2.41, 95% CI: 1.16-6.08), previous TB treatment (OR = 2.64, 95% CI: 1.22-6.67), hypo-albuminemia (OR = 2.10, 95% CI: 1.53-2.88), HIV co-infection (OR = 2.72, 95% CI: 1.66-4.46), and CD4 count <200 mm in HIV-infected individuals (OR = 2.03, 95%CI: 1.26-3.27). Risk factors associated with post-TB hearing loss include baseline hearing problems (OR = 1.72, 95% CI: 1.30-2.26), and HIV co-infection (OR = 3.02, 95% CI: 1.96-4.64).
This systematic review and meta-analysis found that long-term physical post-TB sequelae including respiratory, hepatic, and hearing impairment were associated with a range of socio-demographic, behavioral, and clinical factors. Identification of these risk factors will help to identify patients who will benefit from interventions to reduce the burden of suffering from post-TB treatment.
Healy Medical Research Raine Foundation, the Australian National Health and Medical Research Council, and Curtin University Higher Degree Research Scholarship fund the study.
结核病后遗症给结核病幸存者的管理带来了重大挑战,即使在成功治疗后,也常常导致持续的健康问题。识别与结核病后遗症相关的风险因素对于改善结核病幸存者的预后和生活质量至关重要。本系统评价和荟萃分析旨在识别结核病幸存者中长期身体后遗症的相关风险因素。
我们系统检索了Medline、Embase、PROQUEST和Scopus数据库,以查找截至2023年12月12日关于结核病幸存者长期身体后遗症的研究。主要关注的结果是量化长期身体后遗症(即呼吸、肝脏、听力、神经、视觉、肾脏和肌肉骨骼后遗症)的风险因素。我们纳入了所有经历过长期身体后遗症的结核病患者。对于仅报告一次的风险因素,我们采用叙述性综合分析;对于有两项或更多研究的主要结果,我们采用随机效应荟萃分析。研究结果以比值比(OR)和95%置信区间(CI)呈现。使用漏斗图和Egger回归评估发表偏倚,并通过Galbraith径向图检查异质性。该方案已在国际系统评价注册平台(Prospero,注册号:CRD42021250909)上注册。
叙述性综合分析纳入了来自28个国家的73篇文章,共31,553例接受过结核病治疗的患者,其中64项研究纳入了荟萃分析。与结核病后肺部后遗症相关的风险因素包括年龄较大(OR = 1.62,95% CI:1.07 - 2.47)、既往结核病治疗史(OR = 3.43,95% CI:2.37 - 4.97)、吸烟(OR = 1.41,95% CI:1.09 - 1.83)、饮酒(OR = 1.84,95% CI:1.04 - 3.25)、涂片阳性的肺结核诊断(OR = 3.11,95% CI:1.77 - 6.44)以及治疗开始时肺部病变的影像学证据(OR = 2.04,95% CI:1.07 - 3.87)。与结核病后肝损伤相关的风险因素包括既往肝炎(OR = 2.41,95% CI:1.16 - 6.08)、既往结核病治疗(OR = 2.64,95% CI:1.22 - 6.67)、低白蛋白血症(OR = 2.10,95% CI:1.53 - 2.88)、HIV合并感染(OR = 2.72,95% CI:1.66 - 4.46)以及HIV感染者的CD4计数<200/mm(OR = 2.03,95% CI:1.26 - 3.27)。与结核病后听力损失相关的风险因素包括基线听力问题(OR = 1.72,95% CI:1.30 - 2.26)和HIV合并感染(OR = 3.02,95% CI:1.96 - 4.64)。
本系统评价和荟萃分析发现,结核病后的长期身体后遗症,包括呼吸、肝脏和听力损害,与一系列社会人口学、行为和临床因素有关。识别这些风险因素将有助于确定哪些患者将从干预措施中受益,以减轻结核病治疗后的痛苦负担。
希利医学研究雷恩基金会、澳大利亚国家卫生与医学研究委员会以及科廷大学高等学位研究奖学金为该研究提供了资金支持。